Skip to content
Vanity or Vice

The Verdict Index · by Rachel

The internet has opinions. So do I.

Treatments, buzzy ingredients, suspiciously expensive little jars, devices, trends, and beauty promises get one honest, researched ruling: worth the vanity, interesting with conditions, still missing receipts, or a beautifully packaged no.

Personal does not mean pulled from thin air.

I am not pretending every face, budget, tolerance, or appetite for maintenance is the same. I am telling you where I land—and exactly what made me land there. The evidence matters. The formula matters. The price tag and the Tuesday-night reality of using the thing matter too.

Skincare serum bottle presented with ingredient references

Freshly judged · Claims & Evidence

The Molecule Earned Its Reputation. Your Retinoid Routine Has Not.

Retinoids have strong evidence, but tretinoin, retinol, retinaldehyde and cosmetic retinoid systems are not interchangeable. Match the exact molecule, formulation, indication and tolerability to the claim.

Rachel's latest rulingLast updated September 19, 2026
Read my verdict

The Verdict Index

Every ruling, sortable. No polite little shrug.

No ten-point scores and no fake objectivity. Filter by verdict, sort by evidence or by what a thing costs to keep, open any row for the terms and what would change my mind.

Every judgment this publication has issued, in one place, with the reasoning one click away.

A verdict here is not a score. Good and bad are almost never the useful answer. The useful answer is worth it for whom, on what evidence, at what cost, with what maintenance attached — and what would change the conclusion. That last one is the test I hold myself to. A verdict that cannot say what would overturn it is an opinion wearing a lab coat.

Two scales, and they are deliberately separate. Evidence is how much is actually established in people, not how excited the mechanism sounds. Pleasure or treatment is a different axis entirely, and collapsing the two is how a lovely, beautifully made, completely unnecessary product ends up described as either a scam or a breakthrough when it is neither. Plenty of things on this list are bought for how they feel. That is a real reason. It is just not an efficacy claim.

Filter it, sort it, search it. Open a row for the terms. Nothing here links to a shop.

53 judgments

With conditionsNon-surgical tightening, over a decadeChoose the smaller result on purpose, or discover the total by accident.TreatmentMaintenance Math
Worth it for
Someone who wants a modest change, values being able to decline future sessions, and has seen the long-horizon cost before starting rather than during it.
Skip it if
You are choosing non-surgical primarily because it appears cheaper at the first appointment. The ten-year comparison depends on your actual price, cadence and whether you keep repeating treatment.
What it treats
The gap between a per-session price and years of maintenance. It does not tell you which treatment suits your anatomy — that needs a provider who can examine you — only how to make the recurring cost visible.
Maintenance
Model it from the exact plan rather than assuming an eighteen-month interval applies to everyone. The absence of a monthly bill is exactly why long-term totals stay invisible.
Cost over time
On the illustrative inputs used here, about 17,000 dollars over ten years for the two energy routes, against 12,000 to 20,000 once for surgery. Both figures move enormously by market, extent, cadence and individual plan.

What would change this: Your own quotes and your actual recommended cadence, which are the only numbers that matter. Better long-term durability data could also change the decade arithmetic substantially.

Read the reasoning →Next decision: Open Spa Intelligence →
Worth itWhat survives stoppingAlmost all of it is rent. Three lines on the shelf are a purchase.TreatmentMaintenance Math
Worth it for
Anyone about to start something with a schedule attached. The answer to what happens if I stop should arrive before the first payment, not during the second year.
Skip it if
Nobody, but note the register: these are typical ranges, and the timeline that applies to you depends on product, dose, technique, anatomy and luck.
What it treats
The difference between an intervention that creates something and one that mainly holds something in place. Most suppressive effects fade after stopping; repeated neuromodulator treatment is one reason not to turn that rule into an absolute.
Maintenance
One question, asked once, before you agree. It costs nothing and it reprices roughly half of these decisions.
Cost over time
Free, and the highest-return thirty seconds available in any consultation.

What would change this: Nothing about the principle. What moves is the individual durations and what persists after repeated treatment, so ask for the figures and uncertainty that apply to your product and your face rather than trusting a general range, this one included.

Read the reasoning →Next decision: Take it to Spa Intelligence →
With conditionsAt-home laser caps for pattern hair lossThe category earned it. The specific hat still has not been compared to its neighbor.TreatmentDevices
Worth it for
Mild to moderate pattern hair loss in someone willing to hold the device protocol for months. Combination use with minoxidil now has positive pooled evidence, but the size of the incremental benefit and the performance of any particular cap remain device- and protocol-specific.
Skip it if
You are choosing between two caps because one has more diodes, costs more, or has better reviews. No head-to-head efficacy trial currently tells you that those shopping signals predict a better result.
What it treats
Hair density in pattern hair loss. Sham-controlled trials support the device category, and 2025 pooled evidence also supports an incremental benefit when low-level light or laser therapy is added to minoxidil.
Maintenance
Several sessions a week, over months, then ongoing management of a progressive condition. Use the schedule for the exact device rather than a category average.
Cost over time
Hundreds to thousands of dollars across cleared devices. The price spread is not an efficacy spread, because no two products have been shown head to head to earn it.

What would change this: One good head-to-head device trial. The category can tell you that low-level light is useful. It still cannot tell you whether the 300-diode cap earns the premium over the 100-diode one.

Read the reasoning →Next decision: Open the Claim Decoder →
With conditionsChoosing an exfoliating acidSettle the lane, then the problem. The decimal comes last.TreatmentRoutines & Ingredients
Worth it for
Anyone comparing bottles on percentage, and anyone who concluded an acid stopped working when what actually changed was the formulation around it.
Skip it if
Anyone already using a retinoid they are still getting used to. Add one variable at a time, and let the retinoid finish introducing itself first.
What it treats
Which acid suits which problem, and why the number on the front cannot settle it. It does not tell you a strength — nothing on a cosmetic label can.
Maintenance
Its own night, at whatever frequency your skin tolerates, which is a number you can only find once nothing else is competing for the evening.
Cost over time
Ordinary. This is a category where the expensive versions are mostly buying you a nicer texture and a better vehicle, both of which are real things to buy.

What would change this: Published free-acid values and formulation pH on cosmetic labels. One line on the back of the bottle would make this entire category comparable, and its absence is the reason articles like this have to exist.

Read the reasoning →Next decision: Build the routine · Skincare Intelligence →
With conditionsUltraClear 2910 nm fractional laserA real platform. The machine name is not the treatment plan.TreatmentBefore You Book
Worth it for
Someone booking a consultation who will ask which module, at what depth, coverage and number of passes, for which specific problem. The published evidence is decent and it is mode-specific, which means it only transfers to you if your protocol matches the one that was studied.
Skip it if
Anyone shopping the brand name rather than the protocol. Anyone expecting deep resurfacing results from a superficial pass, or superficial recovery from a deep one — in the published data the result and the downtime move together, which is the honest version. Laser-Coring is a separate procedure conversation, not the premium tier of a facial menu.
What it treats
Photoaging, texture, rhytides and acne scarring, at depths and coverages that differ by module. Scars are architectural, and a laser can be excellent and still not release a tethered one.
Maintenance
Courses rather than single sessions in most of the studies — commonly three treatments six to eight weeks apart, then whatever the provider recommends to hold it.
Cost over time
Resurfacing sessions run roughly 500 to 5,000 dollars depending on depth and market. Price the course and the maintenance, not the first appointment.

What would change this: Larger trials across the full Fitzpatrick range, and per-module rather than per-platform reporting. Two temporary hyperpigmentation cases appeared even in a controlled research setting, so all skin types deserves data rather than reassurance.

Read the reasoning →Next decision: Take it to Spa Intelligence →
With conditionsMedicube Booster Pro X2, 249 dollars at the September 7 price checkVanity for the disciplined. Vice for anyone buying seven promises instead of one realistic job.BothDevices
Worth it for
Someone who already knows they enjoy home-device routines, wants one object rather than four, and is content with incremental hydration, texture, glow and temporary definition.
Skip it if
Anyone who abandons devices once the novelty goes — the X2 does not contain a personality transplant. Anyone whose real concern is significant laxity, deep wrinkles, scarring, vascular redness or pigment that needs diagnosis. And anyone who already owns an LED mask and a microcurrent device they actually use.
What it treats
Hydration, texture, glow and temporary definition. Not dermal remodeling — and the mode percentages do not add together into it.
Maintenance
Five to ten minutes a session, up to several times daily depending on the mode, plus charging, cleaning, product pairing and an app that several features depend on.
Cost over time
249 dollars at the September 7, 2026 price check, against a 299-dollar regular price, plus an app dependency that makes this closer to consumer electronics than to a gua sha. Software support is part of how long the hardware stays useful.

What would change this: The study architecture published alongside the mode-specific percentages — sample size per endpoint, comparator, blinding, protocol, and what is left once use stops. The finished-device testing is the right instinct; it is currently ungradeable from the public page.

Read the reasoning →Next decision: Price the whole year · Spa Intelligence →
With conditionsAt-home microneedlingFind out what is in your hand before you decide anything else.TreatmentDevices
Worth it for
A short-needle cosmetic roller, used by someone who wants a mild exfoliation habit and holds their expectations at the level of its actual claims.
Skip it if
Anyone treating scarring at home. Anyone with a clotting or bleeding disorder, on a blood thinner, with eczema or diabetes or a compromised immune system — those are stated cautions and belong with a clinician. And anyone whose device will not tell them its needle length.
What it treats
For the cleared in-clinic procedure — facial acne scars and facial wrinkles. For the cosmetic roller, appearance and exfoliation, which is a smaller claim honestly made.
Maintenance
Cleaning between every use exactly as directed, never sharing the device, and replacing needle heads on the schedule rather than when they visibly dull.
Cost over time
10 to 40 dollars for a roller, 80 to 300 for a home pen, 200 to 700 a session in clinic. The middle option is the only one where cost and exposure point in opposite directions.

What would change this: Mandatory, plain needle-length disclosure on consumer listings. Almost every question a buyer needs answered here is answered by one number that sellers are currently free not to print.

Read the reasoning →Next decision: Check the booking · Spa Intelligence →
Worth itRoutine architectureSubtract before you add.BothRoutines & Ingredients
Worth it for
Anyone whose routine has grown past six steps, anyone whose skin has recently become unpredictable, and anyone about to buy a ninth product to fix a problem the eighth one caused.
Skip it if
Nobody, though if your routine is three products and working, there is nothing here for you to do. A working routine is not a draft.
What it treats
Redundancy, which is a money problem, and conflict, which is a skin problem. It does not tell you which products to own — it tells you how many jobs there are.
Maintenance
One audit, honestly done, and then the discipline of introducing one thing at a time. Both are free.
Cost over time
Negative. This routine got 60 to 80 dollars a year cheaper by removing things.

What would change this: Nothing about the architecture. Your own tolerance is the variable, and it moves — with season, age, medication and what else you are having done. Re-audit when your skin surprises you, not on a schedule.

Read the reasoning →Next decision: Take it to Skincare Intelligence →
Worth itMaintenance math, as a methodPrice the third year, not the first appointment.Maintenance Math
Worth it for
Anyone about to book, buy or commit to something with a schedule attached. The method costs nothing and changes roughly half of these decisions.
Skip it if
Nobody, but be honest that this is arithmetic and not advice. Which route suits your face is a separate question, and for the clinical routes it needs a provider who can see it.
What it treats
The gap between a quoted price and a lived one. It does not tell you what works — it tells you what you are actually agreeing to.
Maintenance
Ten minutes with a calculator, once, before the decision rather than after it.
Cost over time
Nothing, and it is the highest-return thing on this page.

What would change this: Nothing about the method. The figures move constantly — check them against your own provider and your own basket rather than trusting a national range, including this one.

Read the reasoning →Next decision: Take it to Spa Intelligence →
With conditionsAt-home LED masks — exact device, exact jobWorth it, on terms.BothDevices
Worth it for
Someone whose basic routine is already in place, who wants a modest evidence-supported device layer, and who will follow the protocol long enough to judge it. For acne, the exact device needs acne evidence or an appropriate cleared indication rather than merely blue LEDs.
Skip it if
You are buying it for melasma or undiagnosed pigment. You are assuming irradiance alone tells you the dose. Or you already own a device you stopped using — that is data about the slot, not the hardware.
What it treats
Fine lines and texture with selected home protocols. Mild-to-moderate acne with selected red-blue home devices. Not generic pigment treatment, and not a universal claim for every mask.
Maintenance
Protocol-specific. The useful number is the schedule actually studied for the exact device, not a category average invented after checkout.
Cost over time
Usually one large hardware purchase rather than a recurring appointment bill. The ownership cost is mostly the device, replacement risk and the time you keep giving it.

What would change this: Independent per-model reporting that puts wavelength, irradiance, session time and radiant exposure in the same place, plus controlled finished-device trials. That is what turns the glowing object into a comparable intervention.

Read the reasoning →Next decision: Check the booking · Spa Intelligence →
With conditionsChoosing a retinoid productSettle the lane before you argue about the number.TreatmentProduct Reality Checks
Worth it for
Anyone comparing bottles on percentage, anyone who has abandoned a retinoid once already, and anyone about to pay a premium for a chart that places a cosmetic next to a drug.
Skip it if
Nobody needs to skip retinoids on principle. But if you are managing acne or pigment that has not responded, the useful next step is a clinician rather than a fourth bottle.
What it treats
Which product you are actually buying, and therefore what its claim is allowed to mean. It does not tell you which one suits your face.
Maintenance
It rearranges the routine around it — a richer moisturizer, sunscreen moving from optional to non-negotiable, and acids losing their old slot. That knock-on is part of the price.
Cost over time
From a few dollars to several hundred, and the correlation with strength is close to nothing. The premium sometimes buys a vehicle you will keep using, which is a real thing to buy.

What would change this: Finished-product testing from the cosmetic lane, published and comparable. The molecule evidence has been settled for years — it is the bottle that keeps arriving unexamined.

Read the reasoning →Next decision: Open Skincare Intelligence →
With conditionsThermage and monopolar RFA real, modest tightening. It does not need to impersonate a facelift.TreatmentTreatments & Procedures
Worth it for
Mild to moderate laxity, where the expected change fits the price and the provider can explain the device rather than recite its brand story.
Skip it if
You want structural repositioning, or you have been told that no needles means nothing can go wrong. It is a heat-based medical device and burns are possible.
What it treats
Wrinkles and laxity. Reviews report improvement across monopolar, bipolar and multipolar systems, with enough variation in settings, schedules and outcome scales that no single percentage travels well from a study to a clinic.
Maintenance
Often a single session, which is genuinely unusual in this company. The result develops gradually, so ask when the practice judges it and what would justify a repeat rather than treating annual maintenance as a subscription.
Cost over time
One appointment, and an expensive one. Price the whole horizon — treatment, travel, follow-up and a realistic repeat interval — before calling it a one-off.

What would change this: Independent comparative data rather than manufacturer-linked non-inferiority trials. Those show the category is evolving; they do not show that every monopolar system, at every clinic setting, is equivalent.

Read the reasoning →Next decision: Check the booking · Spa Intelligence →
With conditionsUltherapy and microfocused ultrasoundA modest lift, and one word doing far more work than the device.TreatmentTreatments & Procedures
Worth it for
Mild to moderate laxity, someone who wants a bounded non-surgical change, an anatomy-literate provider, and several months of patience.
Skip it if
You need skin excised or deep structure repositioned. Nonsurgical facelift is a marketing metaphor, not a procedural equivalence.
What it treats
Modest facial and neck tightening. Reviews report investigator-rated improvement and generally good satisfaction, across studies that vary in treatment map, energy, follow-up and rating scale.
Maintenance
Remodeling develops over months, which is also what makes the before-and-after photographs so vulnerable to lighting, weight, expression and head angle.
Cost over time
One substantial session rather than a course, then a judgment about repeating. Ask when the result is assessed and what would make a repeat reasonable rather than automatic.

What would change this: Trials using a common improvement scale. One meta-analysis noted that how improvement is classified can make response rates look considerably more generous than the change on the face.

Read the reasoning →Next decision: Check the booking · Spa Intelligence →
With conditionsRF microneedling and Morpheus8Not canceled, and no longer casual. The 2025 warning raised the burden of proof.TreatmentTreatments & Procedures
Worth it for
Selected acne scarring, with a licensed provider who can state the intended depth in each area and say whether volume loss is being avoided.
Skip it if
The practice cannot discuss the October 2025 FDA safety communication calmly, or still describes this as basically microneedling with a little heat. That communication followed reports of burns, scarring, fat loss, disfigurement and nerve damage, some requiring medical or surgical intervention.
What it treats
Acne scars, wrinkles, laxity and texture, on a heterogeneous literature: devices, needle configurations, parameters and outcome scales all vary, and some recent reviews carry device-industry affiliations.
Maintenance
A series, then a judgment. Ask what is expected, what is not, and who is medically responsible after hours. Send us a photo if you are worried is not an emergency plan.
Cost over time
Priced per session and quoted as a course. The complication pathway is part of what you are buying, and it never appears on the price list.

What would change this: A clean population-level complication rate. Adverse-event reporting can identify a serious signal and cannot supply a denominator — which is an argument for better consent and follow-up, not for ignoring the signal.

Read the reasoning →Next decision: Price the whole year · Spa Intelligence →
Worth itFractional CO2 resurfacingA serious tool. An ablative laser should come with an ablative level of explanation.TreatmentTreatments & Procedures
Worth it for
A defined target — atrophic acne scars, a surgical or traumatic scar, real photodamage — with a provider skilled across your skin type and a calendar that can absorb the recovery.
Skip it if
The pitch is one laser, fresh new skin, basically no downtime. Fractional describes the delivery. It does not describe how your week will go.
What it treats
Selected atrophic scars, photoaging and texture. More injury can buy more remodeling, and more injury also asks more of the skin. That trade is the whole decision.
Maintenance
Ask for four dates rather than one downtime estimate: re-epithelialization, when ordinary skincare resumes, when most people look socially presentable, and when lingering redness stops being considered routine.
Cost over time
Never one line item. Price the aftercare, the follow-up, a possible staged second session and a pigment-management visit before calling it affordable.

What would change this: Better representation of Fitzpatrick IV to VI in the trial literature. Post-inflammatory hyperpigmentation is the central risk of resurfacing, and it is exactly where the published evidence is thinnest.

Read the reasoning →Next decision: Open Spa Intelligence →
With conditionsIPL and BBL photofacialsElegant for a defined light target. For anything vaguer, an expensive way to discover that pigment has opinions.TreatmentTreatments & Procedures
Worth it for
A clearly defined light-responsive target — vessels, diffuse redness, sun-related lentigines — with a provider who routinely treats your skin tone on that exact platform.
Skip it if
Melasma, or any pigment change that has not actually been diagnosed. Pigment is not a one-word diagnosis, and heat and light can aggravate melasma in some people.
What it treats
Selected vascular and photodamage findings. A systematic review of 16 studies and 637 participants found improvement — and judged nine of those studies low methodological quality, with no consensus on treatment parameters.
Maintenance
A series, then upkeep, and a calendar that steers around the beach fortnight. Recent tanning changes how much melanin is available to absorb the light.
Cost over time
Price the course rather than the promotional session, and leave room for a pigment-management visit. It is a real possibility and it belongs in the figure.

What would change this: Consensus treatment parameters, and trials that are not judged low quality. Also better phototype representation, since pigment risk is the central concern here and darker skin is where the published evidence is thinnest.

Read the reasoning →Next decision: Price the whole year · Spa Intelligence →
Worth itProfessional laser hair removalReduction, reliably. Removal, not as a promise.TreatmentTreatments & Procedures
Worth it for
Dark hair on skin the device and settings actually suit, in a practice that will change parameters rather than run a preset.
Skip it if
Blonde, gray, white and some red hair. There is very little pigment for a conventional hair laser to aim at, and no wavelength fixes that.
What it treats
Long-term hair reduction. A 2022 systematic review found substantial reduction across alexandrite, diode and Nd:YAG systems, with wide variation in the ranges.
Maintenance
A course first, then maintenance for some people. Maintenance is not evidence the course failed — it is part of the ownership cost, and it should be quoted before you buy a package.
Cost over time
The course plus the maintenance, which is a different number from the promotional session price. Ask what the practice considers a complete initial course.

What would change this: Better representation of Fitzpatrick IV to VI in the trial literature, which a systematic review found persistently thin. A provider may have expertise well beyond the published evidence; the evidence itself is not equally deep across every skin tone.

Read the reasoning →Next decision: Price the whole year · Spa Intelligence →
With conditionsTopical vitamin CThe molecule earns it. Your particular bottle has to prove itself separately.TreatmentMedical-Grade Skincare
Worth it for
Photoaging and uneven tone, if you will finish the bottle before it finishes itself. The serum you actually use beats the one you respect from a distance.
Skip it if
This would be the fourth one in the drawer, or the whole case for it rests on a percentage and nothing else.
What it treats
Photodamage, wrinkles and pigmentation, on a small and heterogeneous evidence base that supports benefit without promising a new face.
Maintenance
Daily, and replaced on the schedule the formula needs rather than the one your budget would prefer. Ascorbic acid degrades whether or not you are finished with it.
Cost over time
The premium is largely packaging and stability engineering. That is a reasonable thing to pay for and a poor thing to mistake for proof.

What would change this: Comparative trials between forms. Most of the classic work used L-ascorbic acid, and the phrase vitamin C is not a wire transfer that moves those results into every derivative sharing the family name.

Read the reasoning →Next decision: Take it to Skincare Intelligence →
Beautifully packaged noA dedicated niacinamide serumThe smartest niacinamide purchase is often no purchase.TreatmentMedical-Grade Skincare
Worth it for
Someone whose routine genuinely lacks it, with a specific nameable goal rather than a general one, and skin that gets on with the formula.
Skip it if
Anyone whose moisturizer or sunscreen already carries it — which is most people, and the reason this piece exists. And anyone buying it to fill an empty serum step, because a serum step is not a job.
What it treats
Barrier support and pigment, modestly and reliably. It simply does not need a bottle of its own to do either.
Maintenance
None beyond re-buying it, which is exactly why the duplication survives unnoticed for years.
Cost over time
Around 120 dollars a year that may already be spent, invisibly, inside a moisturizer you like.

What would change this: Nothing about the ingredient — the evidence there is settled and decent. Read the label of what you already own. That is the entire test.

Read the reasoning →Next decision: Set the reassessment date · Skincare Intelligence →
With conditionsSkinMedica TNS Advanced+, 295 dollarsMore than an eye roll. Less than worship.BothMedical-Grade Skincare
Worth it for
Someone with sun protection and a retinoid already in place, who knows this is a cosmetic rather than a treatment, likes the category on its own terms, and can absorb a repeat purchase without resenting it.
Skip it if
Anyone buying it because growth factors sound medical. Anyone whose sunscreen is still occasional — the same money does far more work there. Anyone with irritation they have not yet traced to a source.
What it treats
A general appearance claim within the growth-factor category. Not a specific, isolated, demonstrated effect from this bottle.
Maintenance
A premium repeat purchase, indefinitely, with no endpoint and no moment at which the result is banked.
Cost over time
295 dollars a bottle. Work out the bottles-per-year figure before the first one rather than after the third.

What would change this: A trial of the serum alone, against a credible comparator, with the professional treatments taken out. The strongest study available tested it inside a multi-step protocol, so it cannot separate the product from everything else in the protocol.

Read the reasoning →Next decision: Set the reassessment date · Skincare Intelligence →
With conditionsDermal fillerPersuasive for a defined structural problem. Not for an inventory.TreatmentTreatments & Procedures
Worth it for
A specific structural problem, treated with a product chosen for that job, by an injector who can name the cause they are trying to influence.
Skip it if
The plan grows every visit because balance can always be improved. A treatment plan should be allowed to end before the menu does.
What it treats
Volume and projection. It is not equally good at dynamic lines, texture, pigment or laxity, and separating those at the consultation is most of the work.
Maintenance
Reassessment rather than a refill date. Absorption varies by product and person, and the right interval is not automatically the one the calendar suggests.
Cost over time
A syringe at a time, indefinitely, unless somebody stops. Run the multi-year figure before treating the first appointment as the price.

What would change this: Nothing about the material. What changes a given plan is whether the injector can state the emergency protocol for a suspected vascular occlusion out loud — the FDA warns that inadvertent intravascular injection can cause tissue necrosis, visual impairment including blindness, or stroke.

Read the reasoning →Next decision: Price the whole year · Spa Intelligence →
With conditionsTopical hyaluronic acidBuy it as a humectant. It is not a syringe in a dropper.BothMedical-Grade Skincare
Worth it for
Skin that feels tight and dehydrated, when a standalone bottle visibly does something your moisturizer is not.
Skip it if
Hyaluronic acid is already sitting in half the moisturizers you own. If yours handles comfort, the new dropper is a second layer and a recurring charge.
What it treats
Surface hydration, comfort, and temporary optical smoothing. Not placement, not volume, not structural lift — those belong to the injectable, which is a different product with its own evidence file.
Maintenance
Daily, and only while you keep using it. Hydration is a state, not an achievement.
Cost over time
Anywhere from trivial to absurd, depending largely on how many hyaluronans the box has counted for you. The count is not an endpoint.

What would change this: Finished-product penetration data rather than a molecule-size graphic. A blend of eight weights is a formulation choice, not a result.

Read the reasoning →Next decision: Take it to Skincare Intelligence →
With conditionsNiacinamide, and the percentage raceUseful ingredient. No percentage personality required.TreatmentMedical-Grade Skincare
Worth it for
A job you can name — visible oiliness, barrier support, signs of photoaging — at a concentration you can tolerate every day.
Skip it if
You are reaching for 20 percent because 10 did not work. Four times the concentration is not four times the result, and most of the familiar studies live between 2 and 5 percent.
What it treats
Three separate questions that keep being merged into one: 2 percent for sebum, 4 percent in inflammatory acne, 5 percent for visible aging. Different trials, different outcomes, one word on the box.
Maintenance
Daily, and largely invisible — it is already in the cleanser, the moisturizer and the sunscreen whether you decided that or not.
Cost over time
Cheap in every form, which makes the high-percentage premium difficult to defend on anything except the number itself.

What would change this: Finished-product data at the high concentrations. A manufacturer may hold some. The percentage printed on the front is not it.

Read the reasoning →Next decision: Take it to Skincare Intelligence →
With conditionsCeramide moisturizersCredible, and not automatically better than a plain moisturizer.BothMedical-Grade Skincare
Worth it for
A barrier under load — real dryness, low humidity, frequent washing, or a routine full of irritating actives.
Skip it if
You are choosing it over a plain emollient purely because the box lists three ceramide names. One randomized trial found that using a moisturizer regularly mattered more than which one you used.
What it treats
Barrier lipids: the mortar between cells, alongside cholesterol and free fatty acids. Architecture rather than moisture, which is the whole distinction.
Maintenance
Twice daily, generously, indefinitely. The usual failure is using too little of something too expensive to use properly.
Cost over time
Whatever you allow it to be. There is no evidence premium attached to the word, so the money should be buying texture and tolerance instead.

What would change this: Finished-formula testing behind a lipid-architecture claim. You cannot reconstruct a 3 to 1 to 1 ratio or its lamellar organization from an ingredient list, however long you squint at it.

Read the reasoning →Next decision: Open Skincare Intelligence →
Missing receiptsTopical NAD+ and NMN skincarePromising biology. Premature retail certainty.PleasureRoutines & Ingredients
Worth it for
An early adopter with the basics already in place and money that will not be missed, who understands they are buying an experiment rather than a result.
Skip it if
Anyone who wants a proven outcome, and anyone whose sunscreen and retinoid are not yet consistent. That money does considerably more work one step earlier in the routine.
What it treats
Nothing demonstrated on intact skin. The biology is real and important inside a cell; getting it there through a jar, intact, is the unsolved part.
Maintenance
A repeat purchase with no endpoint and no way to tell whether it is doing anything.
Cost over time
Upwards of 720 dollars a year at the prices this category charges.

What would change this: Controlled human trials of a passive everyday topical on intact skin, showing an outcome rather than a mechanism. A microneedling-assisted study is genuinely interesting and is not the same claim as the one on the box.

Read the reasoning →Next decision: Take it to Skincare Intelligence →
Worth itEctoinVanity in the best sense. Useful support, with less nonsense than the trend cycle usually brings.BothRoutines & Ingredients
Worth it for
Dry or easily dehydrated skin, reactive skin that is weather-stressed or over-treated, and anyone settling a barrier while adjusting to an active. Randomized human data sits behind the hydration and barrier claims, which is more than most trending ingredients can say.
Skip it if
Anyone shopping it as an anti-aging treatment, or expecting anything of it in the sun. And anyone whose sensitive skin needs the whole ingredient list scrutinized — ectoin cannot compensate for something irritating sitting three lines below it.
What it treats
Hydration, barrier support and resilience in stressed skin. A supporting role, played well.
Maintenance
None beyond re-buying it. It is not doing work that unravels the week you pause.
Cost over time
Ordinary serum money, and genuinely substitutable — several well-formulated humectant products do a similar job for less.

What would change this: Head-to-head data against the established hydrators rather than against nothing. The case for ectoin existing is solid. The case for choosing it over what is already on your shelf is the part still missing.

Read the reasoning →Next decision: Open Skincare Intelligence →
Worth itBeta-glucanOne of the better trends of 2026. Kept in its lane, it earns the chair.BothRoutines & Ingredients
Worth it for
Dry, stressed or reactive skin that wants hydration, comfort and barrier support from a well-built formula.
Skip it if
It is already inside a moisturizer you use. Not every good ingredient needs its own shelf, and this is a classic candidate for a redundant fifth step.
What it treats
Hydration, transepidermal water loss and redness — including one split-face, vehicle-controlled study after fractional laser where the treated side did better at days 7 and 14.
Maintenance
None beyond using it. Ease of tolerance is most of the appeal.
Cost over time
Formulated at every price point. Pay more for texture, tolerability and product-specific testing. Do not pay more for the phrase bioactive recovery technology.

What would change this: Product-specific human data instead of a category bibliography. Source, molecular weight and form all change behavior, so a result on one preparation does not transfer to another.

Read the reasoning →Next decision: Take it to Skincare Intelligence →
Missing receiptsVolufilineInteresting ingredient. Overqualified nickname.PleasureRoutines & Ingredients
Worth it for
Someone who enjoys the experiment, likes the rest of the formula, and would be content with subtle plumping or simply good hydration.
Skip it if
Structural hollowing, tear troughs, or anyone expecting procedure-level volume. That is an anatomy problem, and a topical is not addressed to it.
What it treats
A plausible adipocyte mechanism, and one small manufacturer study on breast tissue over 56 days where the day-56 change carried a p value of 0.10.
Maintenance
Low, which counts for something. No appointment, no needle, no recovery window, no retreatment calendar.
Cost over time
A 25-dollar serum bought as a fun experiment and a 150-dollar filler alternative are the same bottle carrying very different evidence debts.

What would change this: A randomized, vehicle-controlled, split-face facial trial using the finished product at the marketed concentration, with objective three-dimensional volume measurement. Nothing less carries a breast result across to an under-eye.

Read the reasoning →Next decision: Open Skincare Intelligence →
With conditionsBeef tallow skincareA rich balm with a real job. Not medicine, and not a recovered ancestral secret.BothRoutines & Ingredients
Worth it for
Very dry skin that likes a heavy occlusive, tolerates it, and is buying the texture rather than the mythology.
Skip it if
Acne-prone skin volunteering as proof of concept, and anyone with diagnosed eczema or psoriasis being invited to swap a treatment plan for a balm.
What it treats
Dryness. It behaves like a rich emollient and occlusive, which is a respectable job that does not need a family tree.
Maintenance
A jar, applied thinly. The only real upkeep questions are oxidation and how the formula is preserved if it contains water.
Cost over time
Anywhere from trivial to a small amber jar priced as though the cow had a trust fund. The price only becomes wrong when the claim inflates.

What would change this: Controlled human trials of finished tallow products for the conditions being claimed. The 2024 scoping review asked for exactly that and reported it missing.

Read the reasoning →Next decision: Take it to Skincare Intelligence →
With conditionsTopical tranexamic acidCredible for melasma. The formulation matters more than the ingredient name.TreatmentMedical-Grade Skincare
Worth it for
Melasma or persistent hyperpigmentation where a non-hydroquinone route is wanted, at 5 percent, with serious photoprotection running alongside it.
Skip it if
You want a general glow. Pigment is several different problems wearing one word, and this is aimed at one of them.
What it treats
Melasma. Several randomized trials put topical 5 percent close to hydroquinone over about twelve weeks. One split-face trial found it no better than vehicle, and that disagreement belongs in the decision.
Maintenance
Months rather than weeks, plus daily sunscreen — pigment recurs, and UV keeps feeding it whatever the serum is doing.
Cost over time
Moderate, and what you are buying is a protocol rather than a product. The sunscreen is the line people underspend on.

What would change this: Finished-product trials on the lower-strength blends. Evidence from microneedling-assisted delivery does not transfer to a plain leave-on, and a 5 percent study does not validate a 2 percent one.

Read the reasoning →Next decision: Build the routine · Skincare Intelligence →
Worth itGlycolic acidIt works. The irritation is the invoice, not proof it is working.TreatmentMedical-Grade Skincare
Worth it for
Texture, dullness and superficial discoloration on skin that tolerates AHAs, at a strength and frequency it can actually hold.
Skip it if
Reactive or rosacea-prone skin. Also any routine that already contains a retinoid, a scrub and a second acid — adding glycolic to that is not a strategy, it is a pile.
What it treats
Exfoliation of the outer stratum corneum. Texture and discoloration improved in the trials; wrinkle improvement did not reach significance.
Maintenance
Two or three nights a week for most people, indefinitely, with sunscreen that is not optional. If the face needs three recovery days after every glow night, the schedule is the problem and not the barrier.
Cost over time
Cheap to buy and expensive to over-stack. The real cost is the repair routine you end up funding when the barrier gives out.

What would change this: Nothing about the exfoliation evidence, which is settled. What would change a specific bottle is its pH and free-acid value, and almost nobody prints either.

Read the reasoning →Next decision: Build the routine · Skincare Intelligence →
With conditionsBakuchiolGentler is the real claim. Equivalent is not.TreatmentMedical-Grade Skincare
Worth it for
Anyone who has genuinely failed retinoids on irritation and would rather use a gentler bottle every night than a stronger one twice a month.
Skip it if
You tolerate a retinoid perfectly well. You would be trading a large evidence base for a small one and usually paying more for the privilege.
What it treats
Wrinkle surface area and hyperpigmentation, on one clean twelve-week head-to-head against 0.5 percent retinol.
Maintenance
Twice daily in the trial that matters, and held long enough for a twelve-week window to mean anything.
Cost over time
Priced like a premium active while carrying a fraction of the literature. That gap is the thing worth noticing.

What would change this: Larger blinded trials that are not open-label and not combination formulas. Separately, human pregnancy-safety data, which does not exist and is not implied by the molecule simply not being a retinoid.

Read the reasoning →Next decision: Take it to Skincare Intelligence →
With conditionsHypochlorous acid sprayFine as an adjunct. Not a treatment, and not a barrier cure.BothMedical-Grade Skincare
Worth it for
Skin that will not tolerate a stripping active, and wound or post-procedure use under professional direction.
Skip it if
You are buying it as the acne treatment. Benzoyl peroxide, a topical retinoid and salicylic acid have far stronger receipts for that particular job.
What it treats
Adjunctive antimicrobial cleansing. The acne trial people quote at you studied sodium hypochlorite, which is a related chemistry and a different evidence object.
Maintenance
Almost none, and that is honestly part of the appeal. No ramp-up, no schedule, nothing to build tolerance to.
Cost over time
Small per bottle and very easy to keep buying. The risk here is not the price, it is the slot it occupies instead of something that treats.

What would change this: Direct human trials of stabilized hypochlorous acid facial sprays for acne. The strong human record at present is antisepsis, not therapy.

Read the reasoning →Next decision: Open Skincare Intelligence →
Worth itAzelaic acidWorth it, when the tube matches the trial.TreatmentMedical-Grade Skincare
Worth it for
Acne-prone skin, papulopustular rosacea and some pigment concerns, at the 15 or 20 percent strengths where the trials actually sit.
Skip it if
You want a wrinkle ingredient. That is not where its clinical data live, and a retinoid is the more honest answer.
What it treats
Inflammatory acne, rosacea papules and pustules, uneven pigment. It works by a different pathway from retinoids and benzoyl peroxide, which is exactly why it survives on skin that is already annoyed.
Maintenance
Daily, and held long enough to be judged fairly. A vehicle you abandon in week three is expensive whatever the tube cost.
Cost over time
Wide, and almost entirely about formulation rather than the molecule. Prescription, compounded and cosmetic versions are not the same purchase.

What would change this: Finished-product trials on the lower-strength cosmetic serums. At the moment they inherit the category literature by association, which is not the same as having it.

Read the reasoning →Next decision: Set the reassessment date · Skincare Intelligence →
Missing receiptsSpermidine supplementationOne result stops the field being dismissed. The other stops it being oversold. Both belong in the same paragraph.TreatmentGrounded Wellness
Skip it if
You want the memory outcome. Twelve months in 100 older adults with subjective cognitive decline did not significantly improve it, or most secondary outcomes.
What it treats
Immune-response and cellular-aging signals in a 2026 pilot of 40 healthy older adults, particularly among vaccine nonresponders.

What would change this: A larger trial that reproduces the pilot's immune signal.

Read the reasoning →Next decision: Decode the claim · Claim Decoder →
With conditionsResveratrol supplementationBetter than does nothing. Still a long way from anti-aging. A risk factor can improve without proving that aging slowed.TreatmentGrounded Wellness
Skip it if
You are treating an improved risk factor as proof that aging slowed.
What it treats
Selected obesity, lipid and blood-pressure measures in particular populations, at higher certainty. A 2026 umbrella review of 45 systematic reviews rated other outcomes moderate to very low.

What would change this: An outcome that is aging itself rather than a risk factor for it.

Read the reasoning →Next decision: Take it to the Claim Decoder →
With conditionsCurcumin and turmeric supplementsNot inert spice cosplay. Also not an anti-aging intervention, and the bioavailable versions carry a liver footnote that is not a footnote.TreatmentGrounded Wellness
Skip it if
You are reading anti-inflammatory as slows aging. Lowering a biomarker in one population is not the same claim.
What it treats
Some inflammatory and metabolic markers, and selected symptoms, in specific populations.
Maintenance
Highly bioavailable formulations have been linked to rare but clinically significant liver injury. That belongs in the decision.
Cost over time
Products differ dramatically in curcuminoid content and absorption technology, so two prices are rarely comparing the same thing.
Read the reasoning →Next decision: Decode the claim · Claim Decoder →
Missing receiptsCoQ10 and ubiquinol supplementsThe blood level moved. The muscle mitochondria were less impressed.TreatmentGrounded Wellness
Skip it if
You are a healthy adult buying it for mitochondrial performance. Twelve weeks raised plasma CoQ10 and left muscle CoQ10, respiratory capacity, glucose homeostasis, aerobic capacity and body composition where they were.
What it treats
Selected clinical uses in specific populations. Supplementation does substantially raise circulating CoQ10.

What would change this: A trial that gets it into the muscle rather than the bloodstream.

Read the reasoning →Next decision: Take it to the Claim Decoder →
Missing receiptsOral NAD+ precursors (NR, NMN)The number moved. The person did not necessarily follow.TreatmentGrounded Wellness
Skip it if
You want the cognitive or vascular outcome. A July 2026 pilot doubled blood NAD+ with NR and still moved neither cognition, cerebral blood flow nor blood pressure in twelve weeks.
What it treats
Raising NAD-related metabolites in human blood or cells. That part is real biological activity.

What would change this: Functional outcomes that stop coming back heterogeneous and null.

Read the reasoning →Next decision: Decode the claim · Claim Decoder →
With conditionsEPA and DHA supplementsA real signal on the aging clocks, measured in months rather than years. Promising evidence, and not permission to turn fish oil into a time machine.TreatmentGrounded Wellness
Skip it if
You are reading biomarker movement as a promise about lifespan, dementia or skin.
What it treats
Selected cardiovascular and triglyceride outcomes. A 2025 post hoc analysis found a small slowing of several DNA-methylation aging clocks over three years.

What would change this: Evidence that the clock movement tracks something the person actually notices.

Read the reasoning →Next decision: Open the Claim Decoder →
Missing receiptsMagnesium supplementation, for agingEssential is not the same as extra being better. A mechanism list is not a clinical endpoint.TreatmentGrounded Wellness
Skip it if
The pitch is the enzyme list rather than a measured outcome.
What it treats
Normal physiological function and deficiency correction. It is a cofactor in more than 300 enzyme systems.

What would change this: A named outcome, in a named population, with a named magnesium form, over a stated period, by a stated amount.

Read the reasoning →Next decision: Open the Claim Decoder →
With conditionsVitamin D supplementationA deficiency question with a real evidence framework behind it. As a longevity strategy, the claim is too vague to test.TreatmentGrounded Wellness
Skip it if
You are already replete and buying it to move a longevity score.
What it treats
Deficiency correction, calcium and phosphate regulation, bone mineralization, neuromuscular and immune function. All established.

What would change this: A trial that names the aging outcome it is trying to move, in adults who are already replete.

Read the reasoning →Next decision: Decode the claim · Claim Decoder →
Missing receiptsOral hydrolyzed collagen peptidesModest changes in some people. The favorable average moves once you separate who paid for the study.TreatmentGrounded Wellness
Skip it if
You expect it to reverse skin aging, rebuild facial structure, or stand in for sunscreen, retinoids or adequate nutrition.
What it treats
Skin hydration, elasticity and wrinkle measures, in short trials.

What would change this: Independently funded trials reporting the same effect as the industry-funded ones.

Read the reasoning →Next decision: Open the Claim Decoder →
Worth itCreatine monohydrateWorth it for strength. Not for the longevity story attached to it.TreatmentGrounded Wellness
Worth it for
Anyone already doing the training the effect depends on.
Skip it if
You are buying it for bone density. Overall bone-mineral-density effects were not significant.
What it treats
Lean mass and leg-press strength, particularly when paired with resistance training.
Cost over time
Monohydrate is the form with the largest research base.

What would change this: Higher-quality randomized trials on cognition in older adults. A 2026 review found only a limited number and said so.

Read the reasoning →Next decision: Open the Claim Decoder →
With conditionsSculptra and poly-L-lactic acidSlow does not mean subtle. It means more time to make the next decision well.TreatmentRegenerative Aesthetics
Worth it for
A defined target, someone who can wait out a gradual result without demanding a top-up because nothing has happened yet, and who will actually do the aftercare massage.
Skip it if
Reversibility matters to you. There is no hyaluronidase equivalent here, so we can dissolve it tomorrow is not available as the default corrective story.
What it treats
Fine lines and wrinkles in the cheek region on label since April 2023, plus the earlier facial wrinkle and contour indications. Other patterns are off-label, which should make the explanation more precise rather than vaguer.
Maintenance
A staged series in which each session should be a fresh decision rather than a prepaid obligation, plus gentle massage several times a day for one to two weeks.
Cost over time
The first vial price is a particularly poor measure of it. Cost the planned series, the follow-up, any added sessions and the clinic maintenance philosophy.

What would change this: Nothing about the mechanism. What should change a given plan is hearing a formula like one vial per decade of age in the consultation — that is sales shorthand, not physiology.

Read the reasoning →Next decision: Price the whole year · Spa Intelligence →
With conditionsTopical HA, skin boosters and fillerThree products sharing a first name. Keep the route attached to the result.TreatmentMedical-Grade Skincare
Worth it for
Anyone about to let one word carry them from a 20-dollar serum to a syringe. That distinction is the entire decision.
Skip it if
Nobody — but note that skin booster is a marketing genre rather than a regulatory category, so the phrase on its own tells you almost nothing.
What it treats
Route. A topical hydrates the surface. An intradermal injection changes selected skin-quality measures. A filler creates physical projection at a chosen plane. All three can produce a smoother photograph, by entirely different roads.
Maintenance
Escalates sharply with route: daily for the serum, a schedule for the booster, a repeat interval plus a provider relationship for filler.
Cost over time
From 20 dollars to several hundred a syringe — and the risk profile scales faster than the price does.

What would change this: Nothing about the principle. What changes for any given product is whether its evidence came from the same route it is being sold in. There is no carrying a balance across.

Read the reasoning →Next decision: Open Skincare Intelligence →
Worth itAt-home device ownership costYour calendar is part of the device specification.Devices
Worth it for
Anyone about to buy a device with a protocol attached — which is all of them.
Skip it if
Nobody, though be honest that this is arithmetic and not a recommendation about which device works.
What it treats
The gap between the sticker price and the ownership stack: hardware, consumables, replacement risk, and the hours the labeled protocol actually asks for.
Maintenance
Two weeks of rehearsing the labeled treatment blocks before you buy. It will not tell you whether the device works. It will tell you whether the routine fits.
Cost over time
Free, and the cheapest test available before checkout.

What would change this: Nothing about the method. Replace every illustrative figure with the actual label, because a category-average schedule describes no real device.

Read the reasoning →Next decision: Check the booking · Spa Intelligence →
With conditionsNeuromodulator maintenance, as a spendNot a 12-dollar decision. A recurring annual system.TreatmentBefore You Book
Worth it for
Someone who knows the annual range, can carry it without quiet resentment, and wants a modest result maintained on purpose.
Skip it if
The only figure you have is a per-unit teaser, the plan grows every visit without being agreed, or the word preventative is covering a spend you cannot sustain.
What it treats
The arithmetic the menu leaves incomplete. Per-unit pricing without expected units is not a price, and 350 dollars an area for three areas three times a year is 3,150 dollars.
Maintenance
Three to four sessions a year, indefinitely. The effect is temporary by design, which makes the calendar the product.
Cost over time
An illustrative 2,000-dollar maintenance year is 6,000 over three years and 10,000 over five — before price rises, and before while we are here quietly adds an area.

What would change this: Nothing about the arithmetic. What changes your number is your own dose, interval and market, so run the proposal you were actually handed rather than a national range.

Read the reasoning →Next decision: Open Spa Intelligence →
Missing receiptsExosomes in beautyBeautifully packaged uncertainty. The mechanism is real; the product receipts are not.TreatmentMedical-Grade Skincare
Worth it for
Readers who want to follow the research. As a purchase, at this point almost nobody.
Skip it if
You are being told it is FDA approved for beauty regeneration. There are no FDA-approved exosome products for aesthetic use, and anyone saying otherwise has told you something useful about themselves.
What it treats
Nothing you can currently buy with a finished-product dossier behind it. The biology is genuinely interesting; the retail and spa-menu outcome claims are not carrying it.
Maintenance
Sold as a series, almost always. Set the stop rule before the first invoice rather than after the third.
Cost over time
Priced like prestige medicine. Premium is not proof, and a mountain of five-star reviews is not identity, manufacturing or human data.

What would change this: A finished product that discloses source, characterization and quality systems, with human outcome data proportional to its claims, in a regulatory lane that matches the use being sold.

Read the reasoning →Next decision: Build the routine · Skincare Intelligence →
With conditionsAt-home radiofrequencyDepends entirely on which box. The category is not the evidence.TreatmentDevices
Worth it for
Someone who has found the specific model with its own published protocol and its own trial, and will run exactly that protocol rather than an approximation of it.
Skip it if
Anyone shopping the category instead of the model. A clinic system generates results a handset borrowed the vocabulary from, and that is the whole trick — the evidence does not travel with the word.
What it treats
Modest facial rejuvenation, under a defined protocol, on the devices that were actually studied. Not on the ones that merely share a name for the technology.
Maintenance
The protocol is the product: session length, frequency and schedule. Off-protocol use is not a smaller version of the result, it is a different thing that has not been tested.
Cost over time
Purchase price divided by the sessions you actually complete. At the schedule on the box it looks cheap. At the schedule people keep, it usually is not.

What would change this: Independent head-to-head trials by model rather than by category, so a buyer could compare the object in front of them instead of the claim standing behind it.

Read the reasoning →Next decision: Price the whole year · Spa Intelligence →
With conditionsAt-home microcurrentPotentially useful, and temporary. Which is not the same as fake.BothDevices
Worth it for
Someone who has seen a short-term cosmetic effect from their exact device, likes it enough to repeat the protocol, and values that occasion-level result. The category is not predictable enough to promise the same visible change to everyone.
Skip it if
Anyone buying a permanent lift in a rechargeable handle. Anyone who will not hold the required protocol. And anyone whose device manual or medical history raises a contraindication or safety question that needs a clinician.
What it treats
Short-term cosmetic changes reported with some devices and users. Not established structural lifting, and not something we can claim accumulates into one.
Maintenance
Device-specific. Many models require frequent sessions and conductive gel. How quickly an effect fades after stopping has not been characterized well enough across the category to state one universal clock.
Cost over time
The handle is bought once; conductive products and time may recur. Work out the protocol and gel-per-year figure for the exact model before the handle, not after.

What would change this: A controlled, independent trial of a specific home device that follows people after treatment stops and measures both the size and durability of the cosmetic effect.

Read the reasoning →Next decision: Check the booking · Spa Intelligence →
With conditionsPeptide serumsA category, not a verdict. Make the evidence belong to the bottle.BothMedical-Grade Skincare
Worth it for
A stable routine, a formula you enjoy, and a product whose evidence you can trace to the actual sequence or the finished formula.
Skip it if
You are expecting injection-like change, or paying a premium because the page carries enough molecular vocabulary to feel medically important.
What it treats
Skin-aging outcomes at category level — a 2026 systematic review and meta-analysis of randomized trials supports that much. It does not make the products interchangeable.
Maintenance
Daily and indefinite, which is exactly what makes the annual figure more revealing than the bottle price.
Cost over time
A 90-dollar bottle that lasts eight weeks is roughly 585 dollars a year. Fine for a formula you love. Harder to defend when the hydration job is already covered elsewhere.

What would change this: Finished-formula testing rather than raw-material studies, with immediate smoothing separated from longer-term structural claims. Watch for the sentence that switches from the retail product to a supplier study halfway through.

Read the reasoning →Next decision: Take it to Skincare Intelligence →
With conditionsBuying an LED maskThe category is plausible. The specific mask still has to show the light math.TreatmentMedical-Grade Skincare
Worth it for
Someone with one outcome in mind who can find wavelength, irradiance and treatment time for the exact model — and who will still be using it in month four.
Skip it if
The product page leads with a celebrity face and an LED count. Bulb count describes coverage, not the dose that reaches skin.
What it treats
Photobiomodulation for named endpoints: wrinkle appearance, inflammatory acne, redness. A device can combine wavelengths and still have far better evidence for one of them than the others.
Maintenance
Ten minutes sounds small until it is several evenings a week for months. Adherence is an efficacy question, not a character one.
Cost over time
Vacation money for a plastic shell, paid once. What it costs per use depends entirely on whether it keeps leaving the drawer.

What would change this: Human evidence on the exact model, or a technically equivalent predecessor, for the outcome being sold. A professional panel study makes a consumer device plausible; it does not finish the proof.

Read the reasoning →Next decision: Build the routine · Skincare Intelligence →

How to read the register

Worth it means the evidence supports the thing for the job it is sold for, and the cost is proportionate to what you get. With conditions is the most common verdict on this site, and the least satisfying to write: it works, for some people, for some concerns, under conditions the marketing does not mention. Missing receipts means the biology is interesting and the human data has not arrived — a category that turns over constantly, and where I expect to be revising. Beautifully packaged no is reserved for things where the claim and the evidence are not on speaking terms.

Sorting by weakest evidence is the most useful thing on this page and the least flattering to the industry. Sorting by cost is the second.

The index reads the verdict card printed inside each article, so it cannot drift from the piece it came from. Change the argument, and the register follows. If something you were looking for is not here, it has not been examined yet — which is a different thing from being dismissed.

Take the whole register with you

The register is published as data as well as a page, because a table of judgments is more useful when you can sort it in your own spreadsheet or quote it without retyping it. Every row carries the subject, the verdict, the evidence rating, whether the thing is pleasure or treatment, the maintenance it creates, the cost line, and what would overturn the conclusion.

Free to quote with attribution and a link to the source article. Nothing in it links to a shop, and no row carries an affiliate parameter, so the export is exactly the object on this page. If you are building something that needs beauty claims with their evidence attached, take it — that is more useful to everybody than another summary of a summary.

Cost figures inside each verdict are editorial estimates for a mid-sized US market and are inputs to replace with your own, not quotes. Reviewed September 2026.

Browse by current obsession

Choose your rabbit hole. We all have one.

01

Treatments

The appointment, the aftermath, and whether the result is worth the calendar.

Browse the topic
02

Devices

Microcurrent, RF, LED, and other tools judged on dose, evidence, and ownership burden.

Browse the topic
03

Maintenance Math

Year-one ranges, annual upkeep, and the minutes nobody photographs.

Browse the topic
04

Before You Book

Menu literacy, provider questions, downtime, and exit options.

Browse the topic
05

Claims + evidence

The phrases all over your feed, held still long enough to see what they actually mean.

Browse the topic

Something all over your feed?

Put it on my desk.

Send the product, treatment, ingredient, device, or suspiciously confident claim you want examined next.

Every ruling · 117

The full docket, newest first.

More files in this section
  1. Tranexamic Acid Has a Melasma Evidence File. The Route Changes the Risk and the Result.
  2. PRF Under Eyes: What It Can Improve, and What ‘Natural Filler’ Gets Wrong
  3. 10 ‘Medical-Grade’ Skincare Brands Compared: Where the Premium Actually Earns Its Keep
  4. Hydroquinone Still Works. The OTC Shelf Is the Part That Changed.
  5. Azelaic Acid 10% vs 15% vs 20%: The Vehicle and Diagnosis Change the Answer
  6. Revision D·E·J Face Cream: ‘Skin Longevity’ Is a Large Claim for a Moisturizer.
  7. Snail Mucin Has a Better Case for Skin Support Than for Miracles
  8. Salicylic Acid 2% vs a Professional Peel: Same Molecule, Different Exposure
  9. Medik8 Made Retinal Easy to Buy. The Strength Ladder Is Not the Same as a Prescription.
  10. Vitamin C After Microneedling and Lasers: The Antioxidant Is Not the Timing Plan
  11. iS Clinical Has the Cult Following. The Evidence Still Needs Product-Level Citations.
  12. Serum Foundation: Skincare-Infused Makeup Still Has to Be Good Makeup
  13. SkinCeuticals Triple Lipid Restore 2:4:2: The Ratio Is Precise. The Premium Still Needs a Comparator.
  14. SkinCeuticals Earned Its Reputation With Vitamin C. The Rest of the Line Still Has to Earn the Premium.
  15. Obagi Medical Has the Clinical Legacy. The Current Bottle Still Needs Current Evidence.
  16. Skinbetter Science Has a Better Evidence Story Than Most Clinic Brands. The Halo Still Needs Policing.
  17. Alastin Owns the Post-Procedure Conversation. TriHex Still Deserves a Close Read.
  18. EltaMD Made Sunscreen a Dermatology Default. That Does Not Make Every Formula the Same.
  19. Marini SkinSolutions Skin Care Management System Has Logic. Your Routine Still Gets to Edit It.
  20. Jan Marini Is Now Marini SkinSolutions. The System Still Has to Prove More Than Good Taste.
  21. When It Goes Wrong, the Clinic Is Not the Only Place to Take It
  22. The Compounded GLP-1 Argument Is Over. The Face You Bought While You Were On It Is Not.
  23. Bemotrizinol Made It Through. Four Things It Still Does Not Fix.
  24. Korean Sunscreen Won the Headline. Three Backs Is Not a Verdict.
  25. Jowls and Lower-Face Laxity: Filler, RF, Ultrasound, and Surgery Are Solving Different Parts of the Problem
  26. Chemical Peels in Skin of Color Without Buying a New Pigment Problem
  27. Filler Vascular Occlusion: The Rare Complication That Changes the Entire Consent Conversation
  28. Dissolving Filler With Hyaluronidase: Reversal Is Not an Undo Button
  29. The Best Thing About EltaMD UV Clear Is Printed in the Drug Facts
  30. AlphaRet’s Trial Measured Manners, Not Equivalence
  31. I Optimized Everything but the Point
  32. ALASTIN’s $258 Serum Has Biopsies. Who Is It Being Compared To?
  33. Salicylic Acid Is Not a Pore Vacuum. It Is an Active With a Job Description.
  34. Obagi Sells the Same Serum at 10%, 15% and 20% and Compares None of Them
  35. Nobody Has Measured Whether the Law Worked
  36. The Rule of Thirds Was Falsified in White Faces in 1985
  37. One Case Report, and a Search That Hands You a Tumor
  38. Seventeen Percent, Inside the Same Ethnicity
  39. Nobody Has Tested Whether Breathable Nail Polish Breathes
  40. One in Five, Twice, Four Years Apart
  41. The Himba Have Been Wearing Iron Oxide for Centuries
  42. The Allergy Nobody Warns Brides About
  43. Gua Sha Has Real Randomized Trials. They Are About Your Neck.
  44. Thirty-Nine Percent Lead, By Weight
  45. Black Henna Is Not Henna
  46. Ten Years of Not Having Surgery Costs Roughly What the Surgery Costs
  47. Stop Everything Tomorrow. Here Is What You Would Still Have.
  48. Seven Diodes or Three Hundred and Four: Nobody Has Compared Two Laser Caps
  49. Acid Versus Acid: The Percentage on the Front Is the Least Useful Number on the Bottle
  50. UltraClear Is Seven Different Appointments Wearing One Name
  51. Medicube Booster Pro X2: Seven Modes Are Not Seven Clinical Trials
  52. The Roller and the Pen Share a Word and Almost Nothing Else
  53. Most Bloated Routines Are Four Good Products and Five Duplicates
  54. The Three-Year Number: What Four Routes to the Same Face Actually Cost
  55. Buying an LED Mask Means Buying Forty-Three Hours a Year
  56. Vitamin C Is Evidence-Backed. Your Serum Still Has to Survive the Bottle.
  57. Niacinamide Is Already in Half the Routine. Do You Need a Separate Serum?
  58. ZO Sells Step Four Because the System Has a Step Four
  59. The Strongest Recent TNS Advanced+ Study Came With Six Facials Attached
  60. How Hyaluronic Acid Got Sold as a Syringe You Can Afford
  61. Niacinamide Does Several Things Well. Twenty Percent Is Still Not a Personality.
  62. Ceramides Are Not Moisture. They Are Part of the Barrier Architecture.
  63. NAD+ Skincare: Longevity Language Arrived Before the Finished-Product Evidence
  64. Ectoin Has Randomized Human Trials Behind It. It Still Does Not Need a Throne.
  65. Which Beta-Glucan Is Actually in the Bottle?
  66. Volufiline’s Strongest Human Data Came From a Breast Study, Not a Face
  67. Beef Tallow Makes a Good Balm and a Bad Argument
  68. Topical Tranexamic Acid Has Four Trials and They Do Not Agree
  69. Glycolic Acid Improved Texture and Tone. The Wrinkle Result Missed Significance.
  70. Bakuchiol’s Case Rests on Forty-Four People and Twelve Weeks
  71. The Acne Trial People Quote About Hypochlorous Acid Studied a Different Molecule
  72. Azelaic Acid Has Forty-Three Trials. Your Serum May Not Be in Any of Them.
  73. Social Beauty Advice That Helps Instead of Keeping Score
  74. ZO Growth Factor Serum Has New Data. ‘Six Years Younger’ Still Needs Translation.
  75. Growth Factors, EGF, Exosomes, PDRN, and Peptides: ‘Regenerative Skincare’ Needs Better Labels
  76. SkinMedica Has Growth-Factor History. ‘Regenerative’ Still Needs a Precise Definition.
  77. PDRN Has Momentum. Topical Evidence Is Still Catching Up.
  78. Topical PDRN vs Injectable Polynucleotides: Route Is Part of the Evidence
  79. Colorescience Earned the SPF Reputation. The Brush Still Needs Enough Product.
  80. Hyaluronic Acid on Skin, In Skin, and Under It — Three Purchases, Not Three Strengths
  81. Lara Devgan Measures in Millimeters. Who Decides Where to Stop?
  82. Prejuvenation Went Mainstream on Ava Shamban’s Watch
  83. A Journalism Degree Is the Strangest Thing on Doris Day’s CV
  84. Twenty-Five Years In, Jeanine Downie Has Seen This Device Before
  85. A Prescription You Can’t Fill: Dhaval Bhanusali’s Actual Subject
  86. What Does Michelle Henry’s Mohs Training Have to Do With Filler?
  87. Karan Lal on Why the Machine Is the Least Interesting Part
  88. Most of Corey Hartman’s Influence Happens Before the Appointment
  89. Where Mona Gohara Stops Simplifying
  90. Sam Ellis Keeps Putting the Mirror Back Down
  91. Muneeb Shah’s Real Invention Was the Distribution
  92. What Whitney Bowe’s Calendar Was Actually For
  93. Shereene Idriss Says No for a Living. She Also Has a Shelf.
  94. Before You Book #3: An Energy Device Without Parameters Is Just Atmosphere
  95. Before You Book #2: Name the Product, the Goal, and Whoever Is Holding the Syringe
  96. RF Microneedling: Real Scar Signal, Loose Menu Language, and the Gaps That Decide the Booking
  97. Claims Literacy #4: Growth Factors, PDRN, and the Route the Bottle Quietly Drops
  98. Maintenance Math #3: You Cannot Buy Your Way Out of the Schedule
  99. Claims Literacy #2: ‘Clinically Tested’ Names a Room. ‘Clinically Proven’ Owes You a Study.
  100. Maintenance Math #2: Botox Is Priced by the Unit and Billed by the Year
  101. The Exosome Bottle Will Not Tell You What Is In It
  102. At-Home Radiofrequency Has Real Trials. They Belong to Particular Machines.
  103. How Long Microcurrent Lasts Is the Number Nobody Publishes
  104. Peptide Serums: Plausible Mechanisms, Uneven Product Evidence
  105. LED Masks: A Red Light in a Plastic Shell, Priced Like a Vacation
  106. ‘Medical Grade’ Is a Marketing Category, Not a Verdict
  107. FDA Cleared, Approved, Registered: These Words Are Not Interchangeable
  108. Maintenance Math #1: Every Treatment Has a Sequel and Nobody Budgets for It
  109. How to Read a Treatment Menu Before You Book
  110. Where Beauty Meets Better Judgment: The Vanity or Vice Method
  111. The Expensive Routine Problem: When More Products Create Less Clarity
  112. Beauty Evidence Has Levels. Ingredient Research Is Not Finished-Product Proof.
  113. How to Read a Beauty Claim Before You Trust It